(a) The “refolding” or template assistance model postulates … Disappointingly, no such successes have ever been reported in the case of mammalian prions, despite the most intensive of efforts. In vitro conversion of the normal mammalian prion protein, PrPC (C for cellular), can yield a moiety that displays many of the physical and chemical properties characteristic of the disease-associated prion protein, PrPSc (Sc for scrapie), such as aggregation into higher-order quasi-crystalline complexes that are bire-fringent when observed under polarized light (especially upon staining with amyloid dyes, such as Congo red), formation of #selleckchem keyword# fibrils that are identifiable by electron microscopy, and partial

resistance to proteolytic enzymes as identified by digestion with proteinase K.43 Intriguingly, in vitro conversion is subject to a distinct species barrier, just like “true” spongiform encephalopathies.44,45 However, the crucial element that is common to the two definitions mentioned above, and that is absolutely required for the classification of a protein Inhibitors,research,lifescience,medical as a prion, is transmissibility. None Inhibitors,research,lifescience,medical of the experimental procedures that have been reported thus far have unambiguously accomplished the transformation of the cellular prion protein PrPC into a transmissible agent.

There is no dearth of speculations about why this has not been possible: the requirement for additional cellular factors distinct from PrPC, for example, has been invoked on the basis of genetic evidence,46 but has never been proven. Universal consensus about the nature Inhibitors,research,lifescience,medical of the agent will predictably only be reached once synthetic reconstitution from noninfectious material will have been achieved. How prions damage their hosts Notwithstanding all the unresolved problems, Inhibitors,research,lifescience,medical a number of important properties of the infectious agent can be studied, even in the absence of ultimate certainty about its true physical nature. Perhaps the most obvious question regards what accounts for the exquisite propensity of prions to damage the central nervous system (CNS), the only part of the body undergoing

histopathologically and clinically detectable degeneration (Figure 3). Cellular models of prion disease may prove very useful for addressing this question. However, prions replicate inefficiently in most established cell lines. A large number of studies have been performed with a synthetic peptide obtained from the central region of the PrPC molecule, which has been shown to spontaneously ADAMTS5 assemble into amyloid-like structures. Interestingly, this peptide can elicit in vitro many reactions of brain cells that resemble those seen in vivo during the late stages of prion disease: activation of microglia cells, stimulation of intermediate filament production by astrocytes, and even death of neurons, which appears to depend on the presence of the normal prion protein in target cells.47,48 Figure 3.